Boston University Charles River Campus
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston University Charles River Campus sits in the top decile of US sponsors by registered trial count (#234 of 15,742 sponsors by registered trial count).
Boston University Charles River Campus: 104 sponsored US clinical trials, 23 recruiting.
Boston University Charles River Campus sponsors 104 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 72 completed. 2 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anxiety Disorders, with 3 trials.
Top-decile sponsor footprint
Boston University Charles River Campus ranks in the top decile of sponsors by registered trial count (#234 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
72 of 76 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
104 total, page 1 of 3
Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
NCT07659964
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
NCT07455760
Word Learning in Bilingual Typical and Late Talking Children: The Role of Meaning and Input
NCT07600242
Identifying and Addressing Barriers to Retention in the Cervical Cancer Treatment Cascade Among Women With HIV in South Africa: Part 2
NCT06182241
Telehealth Exercise and Mindfulness for Pain in Osteoarthritis - Stage 1B
NCT06684587
Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa
NCT05624931
Project EMPOWER-OCD
NCT07158801
A Pilot Randomized Controlled Trial of the Hopeful and Healthy Living Program
NCT06940843
Positive Minds Strong Joints for Knee Osteoarthritis
NCT06493903
Future Leaders Program: Testing a Youth Leadership, Engagement, and Mindfulness Program
NCT06736522
Neural Mechanisms of Family-Focused Treatment for Youth Depression
NCT06289010
Harness-based Mobility Intervention for Infants With Down Syndrome
NCT06219863
Virtual Reality Intervention for Fear of Heights
NCT06468878
Neuromodulation for a Novel OCD Biomarker and Treatment
NCT05994053
Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
NCT06094192
Alcohol and "Heat of the Moment" Sexual Decision Making
NCT05729256
Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures
NCT05993832
Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
NCT05683223
Investigating Speech Sequencing in Neurotypical Speakers and Persons With Disordered Speech
NCT05437159
Neural Mechanisms of Spatial Representations Beyond the Self
NCT05406349
Improving Spatial Perception and Speech Understanding in Multitalker Mixtures
NCT05260307
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
NCT04895995
Imaging Brain Fluids During Breathing
NCT05180981
College Student Daily Life and Alcohol Use Study
NCT06365125
Conversation Group Treatment for Aphasia: Does it Work?
NCT05113160
A Hybrid Effectiveness Implementation Study of Latino/a Alcohol and Drug Users
NCT04771650
Investigating Individual Differences in Speech Motor Skills in Neurotypical Speakers and Persons With Disordered Speech
NCT07459803
Transcranial Stimulation Combined With Auditory Training
NCT06738030
Motivation for Exercise: A Mood-Based Focus
NCT06706180
Multisite Virtual Reality Intervention for Speech Anxiety
NCT06593847
The Benefits of Nature for Mood and Cognition in Persons With and Without Parkinson's Disease
NCT06483126
Neurostimulation Exosuit Augmented Training (NEAT) in the Clinic
NCT07218107
Translation of Robotic Apparel for Alleviating Low Back Pain
NCT05736393
Mobile App-based Approach for Reducing Pain and Hazardous Drinking: a Pilot Study
NCT06281821
Leadership, Engagement, and Youth Action Program With Mindfulness (LEAP)
NCT06227403
Virtual Reality Intervention for Speech Anxiety
NCT06086756
Development of a Family-Based Transition Planning Program for Culturally-Diverse Youth on the Autism Spectrum
NCT05965648
SibACCESS: Developing a Telehealth Intervention to Address Unmet Psychosocial Needs of Siblings of Children With Cancer
NCT04889755
HEARTS R34 Feasibility Study, Autistic Participants
NCT05608083
Responders to Rhythmic Auditory Cueing in Parkinson Disease
NCT05733819
Telehealth Exercise and Mindfulness for Pain in Osteoarthritis
NCT05524116
Personalized Post-Stroke Gait Rehabilitation Interventions
NCT07212608
Perception in Parkinson's Disease
NCT05483036
Amped-PD: Amplifying Physical Activity Through Music in Parkinson Disease
NCT05421624
Robotic Exosuit Augmented Locomotion (REAL) in the Clinic and Community
NCT05315310
Assessment of the Efficacy of Digital CBT for Anxiety in Adults With Chronic Musculoskeletal Pain
NCT04907656
Process-Based Therapy in an Outpatient Setting
NCT05105568
Alcohol Use and Chronic Pain Among Primary Care Patients
NCT04958200
Effects of Soft Robotic Exosuit on Exercise Capacity, Biomakers of Neuroplasticity, and Motor Learning After Stroke
NCT05138016
Effectiveness Study of STAR (Sensory Therapies and Research) Intervention for School-Based Occupational Therapy Services for Students With Sensory Processing Challenges
NCT04769674
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the Boston University Charles River Campus pipeline
23 recruiting of 104 indexed (22% open); 72 completed (69%).
Phase mix: 2 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Anxiety Disorders (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston University Charles River Campus: open-pipeline peers nationwide
Peers matched on 104 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
Boston University Charles River Campus sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 104 trials (± recruiting share)
- Kessler Foundation · 104 trials · 33% recruiting
- Virginia Polytechnic Institute and State University · 104 trials · 17% recruiting
- Butler Hospital · 103 trials · 9% recruiting
- Augusta University · 106 trials · 12% recruiting
Sponsors near 22% open enrollment (± trial volume)
- Vanda Pharmaceuticals · 22% recruiting · 68 trials
- ALX Oncology · 22% recruiting · 9 trials
- Biosense Webster · 22% recruiting · 18 trials
- Englewood Hospital and Medical Center · 22% recruiting · 18 trials
Related
What to do with this Boston University Charles River Campus page
104 registered trials is a research-attention snapshot, not an endorsement of Boston University Charles River Campus or any single study.
- 23 of Boston University Charles River Campus's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anxiety Disorders is the condition Boston University Charles River Campus studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anxiety Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Boston University Charles River Campus pipeline card: 104 registered trials from official public datasets.Report a data error.